Michael Hurley

About Michael Hurley

Michael Hurley is a director at Alpfa Medical.

Form D filings also name Michael Hurley as a director at PFARADIGM Health, Lunair Medical and R3 Vascular.

Michael Hurley first appears on SEC filings in 2024.

Experience

This experience comes from Michael Hurley's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Hurley in the role, so the role may have started earlier or lasted longer.

AN

Advancium Health Network Current

Board Member

2025 – Present

Alpfa Medical, Inc. Current

Director

2024 – Present · Palo Alto, CA

Develops a device to treat enlarged prostates in men.

RV

R3 Vascular Inc. Current

Director

2024 – Present · Mountain View, CA

LM

Lunair Medical, Inc. Current

Director

2023 – Present · Minneapolis, MN

DM

Deerfield Management Current

Managing Director

2022 – Present

PFARADIGM Health, Inc.

Director

2026 · Palo Alto, CA

BL

Blackstone

Blackstone Life Sciences

2020 – 2022

UC

UCSF Medical Center

Assistant Professor Of Medicine

2016 – 2020

GL

Global Health Consulting Japan Co., Ltd. | 株式会社グローバルヘルスコンサルティング・ジャパン

Consultant

2016

BC

Bain & Company

Associate Consultant Intern

2009

MS

Morgan Stanley

Analyst Intern

2009

Key Colleagues at Startups

The people Michael Hurley works with at each company, as listed on that company's latest Form D.

R3 Vascular Inc. · Form D, Sep 12, 2024

KR

Kamal Ramzipoor

CTO, Founder

FG

Frederik Groenewegen

Director

JS

John Springer

Director

DN

David Neustaedter

Director

CO

Christopher Owens

President and Chief Executive Officer, director

Amir Abolfathi

Director

NH

Nathan Harrington

Director

Sources

1. SECPFARADIGM Health, Inc. Form D, filed Sep 28, 2026
2. SECAlpfa Medical, Inc. Form D, filed Sep 28, 2026
3. SECLunair Medical, Inc. Form D, filed Sep 15, 2025
4. SECR3 Vascular Inc. Form D, filed Sep 12, 2024